Patients preferences in chemotherapy for advanced non-small-cell lung cancer in Japan.

被引:0
|
作者
Hirose, T [1 ]
Horichi, N [1 ]
Ohmori, T [1 ]
Shirai, T [1 ]
Ozawa, T [1 ]
Ohnishi, T [1 ]
Mitsuru, A [1 ]
机构
[1] Showa Univ, Sch Med, Tokyo 142, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
7242
引用
收藏
页码:676S / 676S
页数:1
相关论文
共 50 条
  • [21] Chemotherapy in recurrent advanced non-small-cell lung cancer after adjuvant chemotherapy
    Valdes, M.
    Nicholas, G.
    Goss, G. D.
    Wheatley-Price, P.
    CURRENT ONCOLOGY, 2016, 23 (06) : 386 - 390
  • [22] PROGNOSTIC IMPACT OF CANCER CACHEXIA IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER RECEIVING CHEMOTHERAPY
    Kimura, Madoka
    Naito, Tateaki
    Wakuda, Kazushige
    Oyakawa, Takuya
    Hisamatsu, Yasushi
    Imai, Hisao
    Tokito, Takaaki
    Ono, Akira
    Akamatsu, Hiroaki
    Taira, Tetsuhiko
    Kenmotsu, Hirotsugu
    Shukuya, Takehito
    Murakami, Haruyasu
    Takahashi, Toshiaki
    Endo, Masahiro
    Yamamoto, Nobuyuki
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S490 - S490
  • [23] Efficacy and Safety of Chemotherapy after Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer
    Camerini, Andrea
    Mazzoni, Francesca
    Scotti, Vieri
    Tibaldi, Carmelo
    Sbrana, Andrea
    Calabro, Luana
    Caliman, Enrico
    Ciccone, Lucia Pia
    Bernardini, Laura
    Graziani, Jessica
    Grosso, Maria Antonietta
    Chella, Antonio
    Allegrini, Giacomo
    Amoroso, Domenico
    Baldini, Editta
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (13)
  • [24] Quality of Life in Patients with Advanced Non-Small-Cell Lung Cancer Receiving Palliative Chemotherapy
    Daroszewski, Cyryl
    Stasiewicz, Malgorzata
    Jazwinska-Tarnawska, Ewa
    Rachwalik, Anna
    Mura, Ewa
    Luboch-Kowal, Joanna
    Drys, Andrzej
    Bogucki, Zdzislaw A.
    Brzecka, Anna
    ADVANCES IN PULMONARY MEDICINE: RESEARCH AND INNOVATIONS, 2019, 1160 : 11 - 18
  • [25] Advanced Non-Small-Cell Lung Cancer
    Kwon, Hyun W.
    Ham, Soo-Youn
    Shin, Sang W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (20): : 1997 - +
  • [26] PATIENTS' AND DOCTORS' PREFERENCES FOR ADJUVANT CHEMOTHERAPY IN NON-SMALL-CELL LUNG CANCER: WHAT MAKES IT WORTHWHILE?
    Blinman, P.
    Hughes, B.
    Crombie, C.
    Christmas, T.
    Hudson, M.
    Veillard, A. S.
    Muljadi, N.
    Millward, M.
    Wright, G.
    Windsor, M.
    Stockler, M.
    McLachlan, S. A.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 44 - 44
  • [27] CHEMOTHERAPY OF ADVANCED NON-SMALL-CELL LUNG-CANCER WITH IFOSFAMIDE AND EPOSIDE
    DRINGS, P
    BECKER, H
    BULZEBRUCK, H
    MANKE, HG
    TESSEN, HW
    TUMORDIAGNOSTIK & THERAPIE, 1990, 11 (02) : 79 - 84
  • [28] Combination chemotherapy for older adults with advanced non-small-cell lung cancer
    Reckamp, Karen L.
    LANCET, 2011, 378 (9796): : 1055 - 1057
  • [29] Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer
    Schiller, JH
    Harrington, D
    Belani, CP
    Langer, C
    Sandler, A
    Krook, J
    Zhu, JM
    Johnson, DH
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (02): : 92 - 98
  • [30] Palliative chemotherapy in advanced non-small-cell lung cancer: Goals and reality
    Beinert, T
    Mergenthaler, HG
    Sezer, O
    Possinger, K
    ONKOLOGIE, 1999, 22 (01): : 63 - 64